To include your compound in the COVID-19 Resource Center, submit it here.

Paclitaxel-coated stent: Feasibility study

ANPI partner Boston Scientific Corp. (BSX, Natick, Mass.) reported final data from the double-blind, international TAXUS II trial of BSX's paclitaxel-eluting stent in which

Read the full 246 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE